Butler M J, Friend E J, Hunter I S, Kaczmarek F S, Sugden D A, Warren M
International Process Development Group, Pfizer Limited, Kent, UK.
Mol Gen Genet. 1989 Jan;215(2):231-8. doi: 10.1007/BF00339722.
The isolation of mutants of Streptomyces rimosus which were blocked in oxytetracycline (OTC) production was described previously. The genes for the early steps of antibiotic biosynthesis mapped together. Genomic DNA fragments of S. rimosus which conferred resistance to OTC and complemented all of these non-producing mutants have been cloned. The cloned DNA is physically linked within approximately 30 kb of the genome of S. rimosus. The gene cluster is flanked at each end by a resistance gene each of which, independently, can confer resistance to the antibiotic. In OTC-sensitive strains of S. rimosus, the entire gene cluster including both resistance genes has been deleted. Complementation of blocked mutants by cloned DNA fragments in multi-copy vectors was often masked by a secondary effect of switching off antibiotic production in strains otherwise competent to produce OTC. This adverse effect on OTC production was not observed with recombinants using low copy-number vectors.
先前已描述了在土霉素(OTC)生产中受阻的龟裂链霉菌突变体的分离情况。抗生素生物合成早期步骤的基因定位在一起。已克隆出龟裂链霉菌的基因组DNA片段,这些片段赋予对OTC的抗性并互补所有这些不产生抗生素的突变体。克隆的DNA在龟裂链霉菌基因组内约30 kb的范围内物理相连。该基因簇的两端各有一个抗性基因,每个抗性基因均可独立赋予对抗生素的抗性。在OTC敏感的龟裂链霉菌菌株中,包括两个抗性基因在内的整个基因簇已被删除。在多拷贝载体中,克隆的DNA片段对受阻突变体的互补作用常常被原本能够产生OTC的菌株中抗生素生产关闭的二次效应所掩盖。使用低拷贝数载体的重组体未观察到对OTC生产的这种不利影响。